{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:22:08Z","timestamp":1759191728726,"version":"3.44.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Canada Graduate Scholarships \u2013 Master\u2019s program"},{"name":"Research Manitoba masters studentship"},{"DOI":"10.13039\/100012172","name":"Breast Cancer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012273","name":"Lotte and John Hecht Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Manitoba\u2019s CFI Matching Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18719-y","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:37:32Z","timestamp":1759171052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the effects of miR-526b and miR-655 on doxorubicin sensitivity in breast cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Reid Morgan","family":"Opperman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujit","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mousumi","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"18719_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"18719_CR2","doi-asserted-by":"crossref","unstructured":"Bukowski, K., Kciuk, M. & Kontek, R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J. Mol. Sci 21 (2020).","DOI":"10.3390\/ijms21093233"},{"key":"18719_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43556-024-00239-2","volume":"6","author":"Y Gu","year":"2025","unstructured":"Gu, Y. et al. Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer. Mol. Biomed. 6, 2 (2025).","journal-title":"Mol. Biomed."},{"key":"18719_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila, M. R. & de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346\u2013354 (2013).","journal-title":"Nature"},{"key":"18719_CR5","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng, Y. & Croce, C. M. The role of MicroRNAs in human cancer. Signal. Transduct. Target. Ther. 1, 15004 (2016).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"18719_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41598-017-18612-3","volume":"8","author":"M Majumder","year":"2018","unstructured":"Majumder, M. et al. COX-2 induces oncogenic micro RNA miR655 in human breast cancer. Sci. Rep. 8, 327 (2018).","journal-title":"Sci. Rep."},{"key":"18719_CR7","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1158\/1541-7786.MCR-14-0543","volume":"13","author":"M Majumder","year":"2015","unstructured":"Majumder, M., Landman, E., Liu, L., Hess, D. & Lala, P. K. COX-2 elevates oncogenic miR-526b in breast cancer by EP4 activation. Mol. Cancer Res. 13, 1022\u20131033 (2015).","journal-title":"Mol. Cancer Res."},{"key":"18719_CR8","doi-asserted-by":"crossref","unstructured":"Shin, B. et al. miR526b and miR655 induce oxidative stress in breast cancer. Int J. Mol. Sci 20 (2019).","DOI":"10.3390\/ijms20164039"},{"key":"18719_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/s12885-019-5771-5","volume":"19","author":"J Tordjman","year":"2019","unstructured":"Tordjman, J. et al. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells. BMC Cancer. 19, 561 (2019).","journal-title":"BMC Cancer"},{"key":"18719_CR10","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41419-020-02921-z","volume":"11","author":"Q Chen","year":"2020","unstructured":"Chen, Q. et al. PIK3R3 inhibits cell senescence through p53\/p21 signaling. Cell. Death Dis. 11, 798 (2020).","journal-title":"Cell. Death Dis."},{"key":"18719_CR11","doi-asserted-by":"crossref","unstructured":"Gervin, E. et al. Chemically induced hypoxia enhances MiRNA functions in breast cancer. Cancers (Basel) 12 (2020).","DOI":"10.3390\/cancers12082008"},{"key":"18719_CR12","doi-asserted-by":"crossref","unstructured":"Hunter, S., Nault, B., Ugwuagbo, K. C., Maiti, S. & Majumder, M. Mir526b and Mir655 promote tumour associated angiogenesis and lymphangiogenesis in breast cancer. Cancers (Basel) 11 (2019).","DOI":"10.3390\/cancers11070938"},{"key":"18719_CR13","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/stem.2426","volume":"34","author":"M Majumder","year":"2016","unstructured":"Majumder, M. et al. COX-2 induces breast cancer stem cells via EP4\/PI3K\/AKT\/NOTCH\/WNT axis. Stem Cells. 34, 2290\u20132305 (2016).","journal-title":"Stem Cells"},{"key":"18719_CR14","doi-asserted-by":"publisher","first-page":"11598","DOI":"10.1073\/pnas.181181198","volume":"98","author":"LD Mayo","year":"2001","unstructured":"Mayo, L. D. & Donner, D. B. A phosphatidylinositol 3-kinase\/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. U S A. 98, 11598\u201311603 (2001).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"18719_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/iub.1749","volume":"70","author":"JM Chen","year":"2018","unstructured":"Chen, J. M., Bai, J. Y. & Yang, K. X. Effect of Resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K\/Akt signaling pathway. IUBMB Life. 70, 491\u2013500 (2018).","journal-title":"IUBMB Life"},{"key":"18719_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11033-025-10430-5","volume":"52","author":"BD Nault","year":"2025","unstructured":"Nault, B. D. & Majumder, M. miR-526b enhances glucose metabolism in breast cancer cells, an effect reversed by targeting the COX-2\/EP4 pathway. Mol. Biol. Rep. 52, 351 (2025).","journal-title":"Mol. Biol. Rep."},{"key":"18719_CR17","doi-asserted-by":"crossref","unstructured":"McGuirk, S. et al. Resistance to different anthracycline chemotherapeutics elicits distinct and actionable primary metabolic dependencies in breast cancer. Elife 10 (2021).","DOI":"10.7554\/eLife.65150"},{"key":"18719_CR18","doi-asserted-by":"crossref","unstructured":"Fenton, S. E., Saleiro, D. & Platanias, L. C. Type I and II interferons in the Anti-Tumor immune response. Cancers (Basel) 13 (2021).","DOI":"10.3390\/cancers13051037"},{"key":"18719_CR19","doi-asserted-by":"publisher","first-page":"e12863","DOI":"10.1111\/sji.12863","volume":"91","author":"P Vidal","year":"2020","unstructured":"Vidal, P. Interferon alpha in cancer immunoediting: from elimination to escape. Scand. J. Immunol. 91, e12863 (2020).","journal-title":"Scand. J. Immunol."},{"key":"18719_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He, Y. et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal. Transduct. Target. Ther. 6, 425 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"18719_CR21","doi-asserted-by":"crossref","unstructured":"De Paz Linares, G. A., Opperman, R. M., Majumder, M. & Lala, P. K. Prostaglandin E2 receptor 4 (EP4) as a therapeutic target to impede breast Cancer-Associated angiogenesis and lymphangiogenesis. Cancers (Basel) 13 (2021).","DOI":"10.3390\/cancers13050942"},{"key":"18719_CR22","first-page":"935","volume":"16","author":"VL Gopaul","year":"2024","unstructured":"Gopaul, V. L. et al. A prospective tumour marker for breast cancer: YWHAB and its role in promoting oncogenic phenotypes. Breast Cancer (Dove Med. Press. 16, 935\u2013956 (2024).","journal-title":"Breast Cancer (Dove Med. Press."},{"key":"18719_CR23","doi-asserted-by":"publisher","first-page":"e963447","DOI":"10.4161\/23723548.2014.963447","volume":"1","author":"P Castel","year":"2014","unstructured":"Castel, P. et al. Rationale-based therapeutic combinations with PI3K inhibitors in cancer treatment. Mol. Cell. Oncol. 1, e963447 (2014).","journal-title":"Mol. Cell. Oncol."},{"key":"18719_CR24","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1038\/s41588-019-0535-3","volume":"51","author":"BA Scholz","year":"2019","unstructured":"Scholz, B. A. et al. WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating. Nat. Genet. 51, 1723\u20131731 (2019).","journal-title":"Nat. Genet."},{"key":"18719_CR25","doi-asserted-by":"publisher","first-page":"e15421","DOI":"10.1016\/j.heliyon.2023.e15421","volume":"9","author":"R Feser","year":"2023","unstructured":"Feser, R. et al. Breast cancer cell secretome analysis to Decipher MiRNA regulating the tumor microenvironment and discover potential biomarkers. Heliyon 9, e15421 (2023).","journal-title":"Heliyon"},{"key":"18719_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1083\/jcb.200201110","volume":"157","author":"Z You","year":"2002","unstructured":"You, Z. et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J. Cell. Biol. 157, 429\u2013440 (2002).","journal-title":"J. Cell. Biol."},{"key":"18719_CR27","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1101\/gad.267708.115","volume":"29","author":"BK Sun","year":"2015","unstructured":"Sun, B. K. et al. CALML5 is a ZNF750- and TINCR-induced protein that binds stratifin to regulate epidermal differentiation. Genes Dev. 29, 2225\u20132230 (2015).","journal-title":"Genes Dev."},{"key":"18719_CR28","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/ijc.33687","volume":"149","author":"S Kitazawa","year":"2021","unstructured":"Kitazawa, S., Takaoka, Y., Ueda, Y. & Kitazawa, R. Identification of calmodulin-like protein 5 as tumor-suppressor gene silenced during early stage of carcinogenesis in squamous cell carcinoma of uterine cervix. Int. J. Cancer. 149, 1358\u20131368 (2021).","journal-title":"Int. J. Cancer"},{"key":"18719_CR29","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/1759-7714.14853","volume":"14","author":"K Kanamori","year":"2023","unstructured":"Kanamori, K. et al. CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma. Thorac. Cancer. 14, 1089\u20131097 (2023).","journal-title":"Thorac. Cancer"},{"key":"18719_CR30","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s00432-013-1541-y","volume":"139","author":"M Debald","year":"2013","unstructured":"Debald, M. et al. Specific expression of k63-linked ubiquitination of calmodulin-like protein 5 in breast cancer of premenopausal patients. J. Cancer Res. Clin. Oncol. 139, 2125\u20132132 (2013).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"18719_CR31","first-page":"182","volume":"4","author":"I Yajima","year":"2014","unstructured":"Yajima, I. et al. GNG2 inhibits invasion of human malignant melanoma cells with decreased FAK activity. Am. J. Cancer Res. 4, 182\u2013188 (2014).","journal-title":"Am. J. Cancer Res."},{"key":"18719_CR32","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/s41598-025-85592-0","volume":"15","author":"C Luo","year":"2025","unstructured":"Luo, C., Xiao, Z. & Yang, W. GNG2 inhibits brain metastases from colorectal cancer via PI3K\/AKT\/mTOR signaling pathway. Sci. Rep. 15, 1787 (2025).","journal-title":"Sci. Rep."},{"key":"18719_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41419-022-04690-3","volume":"13","author":"A Zhao","year":"2022","unstructured":"Zhao, A. et al. GNG2 acts as a tumor suppressor in breast cancer through stimulating MRAS signaling. Cell. Death Dis. 13, 260 (2022).","journal-title":"Cell. Death Dis."},{"key":"18719_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/01.gim.0000250507.96760.4b","volume":"9","author":"D Li","year":"2007","unstructured":"Li, D. & He, L. Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a huge review and meta-analysis. Genet. Med. 9, 4\u20138 (2007).","journal-title":"Genet. Med."},{"key":"18719_CR35","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-019-1576-6","volume":"573","author":"Q Zeng","year":"2019","unstructured":"Zeng, Q. et al. Synaptic proximity enables NMDAR signalling to promote brain metastasis. Nature 573, 526\u2013531 (2019).","journal-title":"Nature"},{"key":"18719_CR36","first-page":"109","volume":"24","author":"W Dong","year":"2020","unstructured":"Dong, W., Sun, S. J., Qin, J. J. & Liu, G. M. Fyn stimulates the progression of pancreatic cancer via Fyn-GluN2b-AKT axis. Eur. Rev. Med. Pharmacol. Sci. 24, 109\u2013121 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"18719_CR37","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ccell.2018.02.011","volume":"33","author":"L Li","year":"2018","unstructured":"Li, L. et al. GKAP acts as a genetic modulator of NMDAR signaling to govern invasive tumor growth. Cancer Cell. 33, 736\u2013751e735 (2018).","journal-title":"Cancer Cell."},{"key":"18719_CR38","doi-asserted-by":"publisher","first-page":"111748","DOI":"10.1016\/j.biopha.2021.111748","volume":"140","author":"X She","year":"2021","unstructured":"She, X., Gao, Y., Zhao, Y., Yin, Y. & Dong, Z. A high-throughput screen identifies inhibitors of lung cancer stem cells. Biomed. Pharmacother. 140, 111748 (2021).","journal-title":"Biomed. Pharmacother"},{"key":"18719_CR39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1089\/089771502753754091","volume":"19","author":"KI Strauss","year":"2002","unstructured":"Strauss, K. I. & Marini, A. M. Cyclooxygenase-2 Inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death. J. Neurotrauma. 19, 627\u2013638 (2002).","journal-title":"J. Neurotrauma"},{"key":"18719_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12935-022-02747-z","volume":"22","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard, S. et al. A review on the role of Cyclin dependent kinases in cancers. Cancer Cell. Int. 22, 325 (2022).","journal-title":"Cancer Cell. Int."},{"key":"18719_CR41","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/0008-5472.CAN-12-2633","volume":"73","author":"V Maire","year":"2013","unstructured":"Maire, V. et al. Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer. Cancer Res. 73, 813\u2013823 (2013).","journal-title":"Cancer Res."},{"key":"18719_CR42","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.dnarep.2017.07.003","volume":"57","author":"CC Chen","year":"2017","unstructured":"Chen, C. C. et al. EXO1 suppresses double-strand break induced homologous recombination between diverged sequences in mammalian cells. DNA Repair. (Amst). 57, 98\u2013106 (2017).","journal-title":"DNA Repair. (Amst)"},{"key":"18719_CR43","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.celrep.2013.04.002","volume":"3","author":"SV Srinivasan","year":"2013","unstructured":"Srinivasan, S. V., Dominguez-Sola, D., Wang, L. C., Hyrien, O. & Gautier, J. Cdc45 is a critical effector of myc-dependent DNA replication stress. Cell. Rep. 3, 1629\u20131639 (2013).","journal-title":"Cell. Rep."},{"key":"18719_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"18719_CR45","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.redox.2013.12.020","volume":"2","author":"BM Gyori","year":"2014","unstructured":"Gyori, B. M., Venkatachalam, G., Thiagarajan, P. S., Hsu, D. & Clement, M. V. OpenComet: an automated tool for comet assay image analysis. Redox Biol. 2, 457\u2013465 (2014).","journal-title":"Redox Biol."},{"key":"18719_CR46","unstructured":"Andrews, S. FastQC: A Quality Control Tool For High Throughput Sequence Data (2010). http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"18719_CR47","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"18719_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"18719_CR49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"18719_CR50","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"18719_CR51","doi-asserted-by":"crossref","unstructured":"Villanueva, R. A. M. & Chen, Z. J. ggplot2: Elegant Graphics for Data Analysis, 2nd edition. Meas-Interdiscip. Res. 17, 160\u2013167 (2019).","DOI":"10.1080\/15366367.2019.1565254"},{"key":"18719_CR52","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"18719_CR53","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett, T. et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 41, D991\u2013995 (2013).","journal-title":"Nucleic Acids Res."},{"key":"18719_CR54","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"18719_CR55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 14, 128 (2013).","journal-title":"BMC Bioinform."},{"key":"18719_CR56","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"18719_CR57","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"issue":"Suppl 4","key":"18719_CR58","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin, C. H. et al. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8 (Suppl 4), S11 (2014).","journal-title":"BMC Syst. Biol."},{"key":"18719_CR59","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ijc.32369","volume":"145","author":"JT Fekete","year":"2019","unstructured":"Fekete, J. T. & Gyorffy, B. ROCplot.org: validating predictive biomarkers of chemotherapy\/hormonal therapy\/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients. Int. J. Cancer. 145, 3140\u20133151 (2019).","journal-title":"Int. J. Cancer"},{"key":"18719_CR60","first-page":"100625","volume":"5","author":"B Gyorffy","year":"2024","unstructured":"Gyorffy, B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov. (Camb). 5, 100625 (2024).","journal-title":"Innov. (Camb)"},{"key":"18719_CR61","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas, N","year":"2012","unstructured":"Cancer Genome Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","journal-title":"Nature"},{"key":"18719_CR62","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico, A. et al. TCGAbiolinks: an r\/bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71 (2016).","journal-title":"Nucleic Acids Res."},{"key":"18719_CR63","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160\u20131167 (2009).","journal-title":"J. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18719-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18719-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18719-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:04:07Z","timestamp":1759172647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18719-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18719"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18719-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is approved by the Brandon University Ethical Approval Committee (approval # 23056) and the Brandon University Biosafety Committee (approval # 2020-BIO-02).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"33584"}}